ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于第八届董事会第二十三次会议决议的公告 | 2025-11-11 | Chinese | |
| 2025年三季度报告 | 2025-10-27 | Chinese | |
| 关于自愿披露创新药HuA21注射液在2025年欧洲肿瘤内科学会（ESMO）年会公布临床研究数据的公告 | 2025-10-21 | Chinese | |
| 关于注射用曲妥珠单抗新增规格的补充申请获批的公告 | 2025-10-10 | Chinese | |
| 关于公司第2期员工持股计划存续期即将届满的提示性公告 | 2025-09-29 | Chinese | |
| 第4期员工持股计划第一次持有人会议决议的公告 | 2025-09-29 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 35333187 | 关于第八届董事会第二十三次会议决议的公告 | 2025-11-11 | Chinese | ||
| 35333175 | 2025年三季度报告 | 2025-10-27 | Chinese | ||
| 35333151 | 关于自愿披露创新药HuA21注射液在2025年欧洲肿瘤内科学会（ESMO）年会公布临床研究数据的公告 | 2025-10-21 | Chinese | ||
| 35333139 | 关于注射用曲妥珠单抗新增规格的补充申请获批的公告 | 2025-10-10 | Chinese | ||
| 35333127 | 关于公司第2期员工持股计划存续期即将届满的提示性公告 | 2025-09-29 | Chinese | ||
| 35333113 | 第4期员工持股计划第一次持有人会议决议的公告 | 2025-09-29 | Chinese | ||
| 35333098 | 关于参股公司PA3-17注射液获准进入关键性II期临床试验的公告 | 2025-09-17 | Chinese | ||
| 35333089 | 关于参加2025年安徽辖区上市公司投资者网上集体接待日活动的公告 | 2025-09-09 | Chinese | ||
| 35333086 | 关于部分高级管理人员减持计划的预披露公告 | 2025-09-04 | Chinese | ||
| 35333069 | 关于独家代理产品重组人卵泡刺激素-CTP融合蛋白注射液获批上市的公告 | 2025-08-25 | Chinese | ||
| 35333055 | 关于公司监事辞职的公告 | 2025-08-21 | Chinese | ||
| 35333046 | 监事会关于公司第三期限制性股票激励计划相关事项的核查意见 | 2025-08-21 | Chinese | ||
| 35333029 | 监事会决议公告 | 2025-08-21 | Chinese | ||
| 35333018 | 董事会决议公告 | 2025-08-21 | Chinese | ||
| 35333004 | 安徽天禾律师事务所关于安徽安科生物工程（集团）股份有限公司第三期限制性股票激励计划回购注销部分限制性股票相关事项之法律意见书 | 2025-08-21 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.